First-Line Camizestrant for Emerging ESR1-Mutated Advanced Breast Cancer

Journal:
The New England Journal of Medicine
Published:
DOI:
10.1056/nejmoa2502929
Affiliations:
29
Authors:
25
Go to article
Institutions Authors Share
AstraZeneca Gaithersburg, MD, United States of America (USA)
2.000000
 0.08
Chaim Sheba Medical Center at Tel HaShomer, Israel
1.000000
 0.04
Bellvitge Biomedical Research Institute (IDIBELL), Spain
1.000000
 0.04
Hospital Universitario Virgen de la Victoria, Spain
1.000000
 0.04
Asan Medical Center (AMC), South Korea
1.000000
 0.04
IRCCS San Raffaele Hospital (HSR), Italy
1.000000
 0.04
Narodowy Instytut Onkologii, Poland
1.000000
 0.04
AstraZeneca, United Kingdom (UK)
1.000000
 0.04
The Winship Cancer Institute of Emory University, United States of America (USA)
1.000000
 0.04
Washington University in St. Louis (WUSTL), United States of America (USA)
1.000000
 0.04
Chang Gung Medical Foundation, Taiwan
1.000000
 0.04
University Hospital of Erlangen, FAU, Germany
1.000000
 0.04
Dana-Farber Cancer Institute (DFCI), United States of America (USA)
1.000000
 0.04
The Royal Marsden Hospital - London, The Royal Marsden NHS Foundation Trust, United Kingdom (UK)
1.000000
 0.04
UPMC Hillman Cancer Center (UPCI), United States of America (USA)
1.000000
 0.04
Ulm University Medical Center, Germany
1.000000
 0.04
BC Cancer Agency (BCCA), PHSA, Canada
1.000000
 0.04
AstraZeneca United States, United States of America (USA)
1.000000
 0.04
Nagoya City University, Japan
1.000000
 0.04
Pôle Santé République - Elsan, France
1.000000
 0.04
Samsung Medical Center (SMC), South Korea
1.000000
 0.04
Weill Cornell Medicine, United States of America (USA)
0.500000
 0.02
New York-Presbyterian Hospital, United States of America (USA)
0.500000
 0.02
University of Health Sciences (SBU), Turkey
0.500000
 0.02
Gülhane Training and Research Hospital, Turkey
0.500000
 0.02
Curie Institute, France
0.250000
 0.01
Centre d’Investigation Clinique Intégré en Biothérapie (CIC-BT), France
0.250000
 0.01
University of Versailles Saint-Quentin-en-Yvelines (UVSQ), France
0.250000
 0.01
University of Paris-Saclay, France
0.250000
 0.01
Interested in Oncology and Carcinogenesis?